Clinical Trial: A First-In-Man Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07330817) titled 'A First-In-Man Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis' on Dec. 11, 2025.

Brief Summary: First-In-Man Single Arm Prospective Study to assess the safety and efficacy of ULTRAVIOLET UHP PTA balloon.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Arterio-venous Fistula Stenosis of Arteriovenous Dialysis Fistula

Intervention: DEVICE: PTA balloon

Angioplasty of a resistant stenotic lesion in the arterio-venous fistula

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Cardionovum GmbH

Published by HT Digital Content Services with permis...